{"name": "Tigris Pharmaceuticals",
 "permalink": "tigris-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/tigris-pharmaceuticals",
 "homepage_url": "http://www.tigrispharma.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2005,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@tigrispharma.com",
 "phone_number": "239.444.5400",
 "description": "",
 "created_at": "Fri Oct 01 05:32:26 UTC 2010",
 "updated_at": "Wed Aug 03 23:05:24 UTC 2011",
 "overview": "\u003Cp\u003ETigris Pharmaceuticals, Inc., a biopharmaceutical company, develops therapeutic technologies for oncology and other areas of unmet medical need. Its products include Aminoflavone that is for the treatment of renal cell, breast, and lung cancer; GGTI-2418, a synthetic peptidomimetic inhibitor of geranylgeranyltransferase, which is for the treatment of lung, breast, pancreatic, and ovarian cancer; GFB-204, a calixarene derivative that is a potent and selective inhibitor of VEGFR and PDGFR tyrosine phosphorylation, which is for the treatment of prostate, pancreas, lung, breast, and renal cell. The company was founded in 2005 and is based in Bonita Springs, Florida.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       75],
      "assets/images/resized/0010/3789/103789v1-max-150x150.png"],
     [[224,
       113],
      "assets/images/resized/0010/3789/103789v1-max-250x250.png"],
     [[224,
       113],
      "assets/images/resized/0010/3789/103789v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President \u0026 CEO",
    "person":
     {"first_name": "Edmundo",
      "last_name": "Muniz",
      "permalink": "edmundo-muniz",
      "image": null}},
   {"is_past": false,
    "title": "COO",
    "person":
     {"first_name": "Anne",
      "last_name": "White",
      "permalink": "anne-white",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$6.5M",
 "funding_rounds":
  [{"round_code": "c",
    "source_url": "http://www.tigrispharma.com/pr_092810_2.html",
    "source_description": "Tigris Pharmaceuticals, Inc. Completes $6.5 Million Private Placement",
    "raised_amount": 6500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 9,
    "funded_day": 28,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Sonostar Capital Partners",
         "permalink": "sonostar-capital-partners",
         "image":
          {"available_sizes":
            [[[150,
               25],
              "assets/images/resized/0026/2607/262607v1-max-150x150.png"],
             [[250,
               43],
              "assets/images/resized/0026/2607/262607v1-max-250x250.png"],
             [[359,
               62],
              "assets/images/resized/0026/2607/262607v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Riverbank Capital Securities",
         "permalink": "riverbank-capital-securities",
         "image":
          {"available_sizes":
            [[[150,
               33],
              "assets/images/resized/0026/1195/261195v1-max-150x150.png"],
             [[250,
               55],
              "assets/images/resized/0026/1195/261195v1-max-250x250.png"],
             [[450,
               100],
              "assets/images/resized/0026/1195/261195v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org": null,
       "person":
        {"first_name": "Neil",
         "last_name": "Flanzraich",
         "permalink": "neil-flanzraich",
         "image": null}},
      {"company": null,
       "financial_org": null,
       "person":
        {"first_name": "Wexford",
         "last_name": "Spectrum Investors",
         "permalink": "wexford-spectrum-investors",
         "image": null}}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "3359 Woods Edge Circle",
    "address2": "Suite 103",
    "zip_code": "34134",
    "city": "Bonita Springs",
    "state_code": "FL",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}